Cargando…

The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS

Detalles Bibliográficos
Autores principales:	Hofman, Isabel Juliana F., Mortera-Blanco, Teresa, Moura, Pedro Luis, Vestlund, Johanna, Larsson, Sigita Venckute, Elvarsdottir, Edda M., Walldin, Gunilla, Tobiasson, Magnus, Sander, Birgitta, Dimitriou, Marios, Jacobsen, Sten-Eirik W., Woll, Petter S., Jädersten, Martin, Hellström-Lindberg, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631652/ https://www.ncbi.nlm.nih.gov/pubmed/35728121 http://dx.doi.org/10.1182/bloodadvances.2022007858

Ejemplares similares

Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts
por: Todisco, Gabriele, et al.
Publicado: (2023)

P713: EXPLORING CLONAL COMPETITION THROUGH 12-YEAR FOLLOW-UP OF AN MDS-RS PATIENT WITH DUAL SF3B1 MUTATIONS
por: Moura, Pedro, et al.
Publicado: (2023)

A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes
por: Elvarsdóttir, Edda María, et al.
Publicado: (2019)

Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs
por: Asimomitis, Georgios, et al.
Publicado: (2022)

Therapy-related MDS dissected based on primary disease and treatment—a nationwide perspective
por: Moreno Berggren, Daniel, et al.
Publicado: (2023)

Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality
por: Dimitriou, Marios, et al.
Publicado: (2016)

Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts
por: Conte, Simona, et al.
Publicado: (2015)

Mutations in histone modulators are associated with prolonged survival during azacitidine therapy
por: Tobiasson, Magnus, et al.
Publicado: (2016)

Comprehensive mapping of the effects of azacitidine on DNA methylation, repressive/permissive histone marks and gene expression in primary cells from patients with MDS and MDS-related disease
por: Tobiasson, Magnus, et al.
Publicado: (2017)

Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations
por: Scharenberg, Christian, et al.
Publicado: (2017)

Myelodysplastic syndromes: moving towards personalized management
por: Hellström-Lindberg, Eva, et al.
Publicado: (2020)

Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS
por: Rautenberg, Christina, et al.
Publicado: (2019)

P1401: UNBIASED, LONGITUDINAL ANALYSIS OF THE INFLAMMATORY RESPONSE OF HSPCS AT THE SINGLE CELL LEVEL RESOLVES CONTROVERSIES REGARDING THE HSPCS STRESS RESPONSE
por: Demerdash, Y., et al.
Publicado: (2022)

A novel SF3B1 variant in a patient with MDS with ring sideroblasts
por: Al‐Ghamdi, Yahya A., et al.
Publicado: (2022)

Genome-wide transcription factor–binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs
por: Subramanian, Shruthi, et al.
Publicado: (2023)

Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial
por: Tobiasson, M, et al.
Publicado: (2014)

SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis
por: Huber, Sandra, et al.
Publicado: (2022)

Omalizumab alleviates pruritus in myeloproliferative neoplasms
por: Landtblom, Anna Ravn, et al.
Publicado: (2023)

HSPCs display within-family homogeneity in differentiation and proliferation despite population heterogeneity
por: Tak, Tamar, et al.
Publicado: (2021)

DRAG in situ barcoding reveals an increased number of HSPCs contributing to myelopoiesis with age
por: Urbanus, Jos, et al.
Publicado: (2023)

Mecom mutation related to radioulnar synostosis with amegakaryocytic thrombocytopenia reduces HSPCs in mice
por: Nagai, Koki, et al.
Publicado: (2023)

SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartment
por: Mian, Syed A., et al.
Publicado: (2015)

SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phase
por: Huber, Sandra, et al.
Publicado: (2022)

P790: THE EXPRESSION LEVEL OF WT1 MRNA IN PATIENTS WITH IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE (ICUS) PROGRESSING TO MYELODYSPLASTIC SYNDROME (MDS)
por: Ye, X., et al.
Publicado: (2022)

Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia
por: Woll, Petter S., et al.
Publicado: (2022)

Genetics instability of wtAAV2 genome and AAV promoter activities in the Baculovirus/Sf9 cells system
por: Savy, Adrien, et al.
Publicado: (2018)

Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN
por: Mestrum, Stefan G. C., et al.
Publicado: (2020)

Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs
por: Iancu, Ortal, et al.
Publicado: (2022)

Isolation, culture, and immunophenotypic analysis of bone marrow HSPCs from patients with myelodysplastic syndromes
por: Ganan-Gomez, Irene, et al.
Publicado: (2022)

SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications
por: Singh, Shalini, et al.
Publicado: (2020)

Somatic mutations in SF3B1 aberrant‐negative MDS‐RS most commonly involved in TP53 genes
por: Li, Xiao, et al.
Publicado: (2022)

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective
por: de Witte, Theo, et al.
Publicado: (2020)

Knock-in of the Wt1 R394W mutation causes MDS and cooperates with Flt3/ITD to drive aggressive myeloid neoplasms in mice
por: Annesley, Colleen E., et al.
Publicado: (2018)

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance
por: de Swart, Louise, et al.
Publicado: (2017)

Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs
por: Boyd, Allison L., et al.
Publicado: (2014)

Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System
por: Shapiro, Jenny, et al.
Publicado: (2020)

Oxidative Stress and X-ray Exposure Levels-Dependent Survival and Metabolic Changes in Murine HSPCs
por: Karabulutoglu, Melis, et al.
Publicado: (2021)

Hematopoietic Stem and Progenitor Cells (HSPCs) and Hematopoietic Microenvironment: Molecular and Bioinformatic Studies of the Zebrafish Models
por: Faisal, Muhammad, et al.
Publicado: (2022)

In vivo observation of multi‐phase spatiotemporal cellular dynamics of transplanted HSPCs during early engraftment
por: Ahn, Soyeon, et al.
Publicado: (2022)

Sulfated Polysaccharide Regulates the Homing of HSPCs in a BMP‐2‐Triggered In Vivo Osteo‐Organoid
por: Dai, Kai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0emtp07jcitf45mgkp608m4oor